BiotechTube
Home/Kuleon Bioscience/Dr. Andy Mattai
DA

Dr. Andy Mattai

Chief Medical Officer

Kuleon Bioscience

Therapeutic Areas

NeuropsychiatrySubstance Use DisordersSchizophreniaObesityPainNeurodegeneration

Kuleon Bioscience Pipeline

DrugIndicationPhase
Substance Use Disorder ProgramAlcohol and Drug Abuse (cocaine, nicotine, methamphetamine)Pre-clinical

Leadership Team at Kuleon Bioscience

AC
Allen C. Barbieri
Co-Founder, CEO
JF
Jeremy Forest
Co-Founder, COO
DG
David Gilles
Co-Founder, CTO
DP
Dr. Paul Tarantino
Chief Scientific Officer–ADVISOR
View full Kuleon Bioscience profile